Rohit Mashani has worked for the healthcare consulting company Veranex since graduating from the MPH Program. Veranex “provides end-to-end solutions” for clients developing new healthcare technologies, explains Manshani. According to its website, the company is a “MedTech conceptto- commercialization partner.” This means that Veranex has teams working with client companies who want to bring a new medical technology to the market, supporting everything from product development and prototyping to market strategy and access. Manshani is part of the Commercial Strategy Market Access Team, which helps design a strategic roadmap for clients so they can take a product and its best value to market.

For example, Manshani works with a client developing a biomarker test. “We prepared a strategic roadmap for them,” he says, which includes clinical and economic evidence to present to insurance companies. When a client approaches Manshani’s team to understand the market viability of a medical product, they perform different informative and market research based on client needs, and build cost quality models to project payouts overtime based on sales. His team presents this to the client along with gaps in the current market and potential pros and cons of developing and marketing the product in different ways.

Manshani had a background in healthcare and pharmaceutical industries in India before joining the MPH Program, and he wanted to understand how to apply this knowledge to larger populations. The MPH Program helped him develop a “wide base” of skills he draws on today in his work with Veranex, including secondary literature review, survey development, qualitative research, policy analysis, and writing op-eds and reports. “The MPH Program supported my development as a consultant,” says Manshani. “It gave me the tools to apply my healthcare knowledge at a wider scale and taught me to how to be a good problem solver.”

Manshani loves communicating with clients while navigating different client dynamics. “If they are very cautious, we might compare and present five different scenarios to perform a sensitivity analysis,” he says. He also loves data analysis, from creating financial projections to summarizing survey results. Manshani appreciates knowing that his work helps make good healthcare options more accessible to millions. “If a medical product is really good and adds value in healthcare,” says Manshani, “we want to identify barriers and work on how to address them.”

Written by Audrey Baker